ArticleInternational journal of molecular sciences2026
Chemotherapy-Mediated Purging Before Testicular Organoid Generation Significantly Reduces Cancer Cells While Not Significantly Reducing Germ Cells.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In total, 37-39% of prepubertal patients present with cancer cells in their testes at the time of diagnosing a hematologic malignancy, and elimination of cancer cells from immature testicular tissue (ITT) remains unsuccessful. Treating testicular single-cell suspensions (TCSs) with chemotherapy before generating testicular organoids (TOs) for in vivo maturation after transplantation could be considered to safely restore fertility with cryo-stored ITT. Five different enzymatic digestion protocols (E1 to E5) were compared but did not show significant differences. For subsequent experiments, E3 using 1.4 mg/mL DNase I and 0.5 mg/mL Liberase was chosen based on the highest recovery of viable testicular cells per mg of tissue and lowest enzymatic concentrations. TCSs were contaminated with a human leukemia HL-60 cell line at concentrations of 4 or 10% and exposed for 24 h to cisplatin (1 µM or 3 µM) or carboplatin (10 µM or 30 µM) prior to TO generation and compared to controls. After eighteen days, hematoxylin and eosin staining showed the development of TOs with forming seminiferous tubules (STs) and interstitium in all conditions. Chemotherapy-treated TOs showed altered germ cell (GC) (DDX4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.